CannabisNewsBreaks – IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) Strengthens Offerings via Acquisition of Cannabis-Infused Edibles Line

IONIC Brands (CSE: IONC) (OTC: IONKF) (FRA: IB3) recently acquired Natural Extractions Inc., which is doing business as Zoots Premium Cannabis Infused Edibles (http://cnw.fm/4dFHj). An article discussing the company reads, “Zoots is an edibles company whose product line includes drops, gummies, energy shots and hard candies manufactured to offer consistent and reliable dosing. The products are currently available at licensed recreational cannabis retailers in Illinois, Washington, Colorado and Massachusetts. . . . ‘Our top-rated Ionic vaporizer pen targets consumers interested in luxury cannabis products that can be discreetly consumed, which make Zoots edibles a natural fit for our brand strategy,’ IONIC Brands chairman and CEO John Gorst stated in a news release. ‘The Zoots acquisition expands our market segments to the popular edibles space and expands our distribution network throughout the United States.’”

To view the full article, visit http://cnw.fm/JRa6r

About IONIC Brands Corp.

IONIC Brands is focused on building a multistate, consumer-focused cannabis-concentrate brand portfolio focusing on the premium and luxury segments. The cornerstone brand of the portfolio, IONIC, is the no. 1 vaporizer brand in Washington state and has aggressively expanded throughout the West Coast of the United States. The brand is currently operating in Washington, Nevada, Oregon and California. IONIC Brands strategy is to be the leader of the highest-value segments of the cannabis market and expand nationally. For more information, visit the company’s website at www.IONIC.social.

NOTE TO INVESTORS: The latest news and updates relating to IONKF are available in the company’s newsroom at http://cnw.fm/IONC

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Feds Say Researchers Should Access Marijuana from Licensed Dispensaries

In their reply to a letter written by Sen. Brian Schatz (D-HI), the Food and Drug Administration (FDA) and the National Institutes for Health (NIH) wrote that researchers should be allowed to access marijuana from licensed dispensaries in states where marijuana is legal instead of being compelled to rely on the single source licensed by the federal government.

In that same letter, the federal agencies discussed how the prohibition of marijuana at the federal level was limiting marijuana research. These limitations include the quality and diversity of research-grade marijuana.

Studies have revealed that the marijuana grown at the only federally licensed facility at the University of Mississippi is closer to industrial hemp than to the marijuana which is readily available in states which have legalized the substance.

The federal agencies say that this discrepancy creates gaps in the way the government and the scientific community understand marijuana products.

The letter from NIH and the FDA comes in response to a letter that was written by Schatz in March asking the agencies about the research agenda they had, their take on what the federal prohibition of marijuana was having on easing marijuana research, and what they thought should be done to make the validity and quality of marijuana research better.

Schatz’s letter was written when Dr. Scott Gottlieb was still the commissioner of the FDA, but the reply had the signature of Norman Sharpless since Gottlieb was no longer at the agency.

The heads of the two federal health agencies discussed at length what their organizations had done and was continuing to do in support of cannabis research, then they proceeded to state that they agree with Schatz that more research should be done. Some of the ongoing clinical studies that they cited included research into how the marijuana laws of states contribute to or influence the use of opioids within those jurisdictions.

NIH and the FDA then pointed out that the federal restrictions, such as having only one licensed supplier of research-grade cannabis, were making it hard for the necessary cannabis research to be done.

The agencies were of the view that any entity with a Schedule 1 license should be free to access marijuana from the licensed dispensaries and retail outlets in states where marijuana is legal so that the research that they conduct is more reflective of the products that consumers use today.

These statements about allowing researchers to access marijuana from licensed dispensaries made all the more sense given that the head of the Mississippi University farm currently supplying all the marijuana used for research is reported to have said that marijuana with an 8 percent THC potency was strong enough and he didn’t see why people needed anything stronger. It was as though he didn’t know that the marijuana on the market can have as much as 25 percent THC!

Analysts think industry participants like HTC Extraction Systems (TSX.V: HTC) and IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) must be wishing that the NIH and the FDA convert their words into actions so that some of the headaches faced by the marijuana industry can come to an end.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsBreaks – IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) Enhances Portfolio with VVG Acquisition

IONIC Brands (CSE: IONC) (OTC: IONKF) (FRA: IB3) recently acquired Vegas Valley Growers North (“VVG”), a Las Vegas, Nevada, state-licensed cultivation and manufacturing firm (http://cnw.fm/Jiia9). An article discussing the company reads, “The VVG acquisition includes a leased 1,700-square-foot production facility and five state licenses for cultivation and manufacturing of both medical and recreational cannabis. VVG is also building a 60,000-square-foot manufacturing facility and has plans for a second 80,000-square-foot facility. Distribution licenses for both medicinal and recreational cannabis products are being processed by state regulators. . . . Also included in the acquisition was VVG’s popular Nevada vape brand, Vegas M Stick, which partners nicely with IONIC Brands’ flagship recreational-branded product — a stylish and sophisticated premium vape pen line called IONIC that has earned customer loyalty and a reputation as a consistent top-10 vape brand in Washington state.”

To view the full article, visit http://cnw.fm/O3kEN

About IONIC Brands Corp.

IONIC Brands is focused on building a multistate, consumer-focused cannabis concentrate brand portfolio focusing on the premium and luxury segments. The cornerstone brand of the portfolio, IONIC, is the no. 1 vaporizer brand in Washington state and has aggressively expanded throughout the West Coast of the United States. The brand is currently operating in Washington, Nevada, Oregon and California. IONIC Brands strategy is to be the leader of the highest-value segments of the cannabis market and expand nationally. For more information, visit the company’s website at www.IONIC.social.

NOTE TO INVESTORS: The latest news and updates relating to IONKF are available in the company’s newsroom at http://cnw.fm/IONC

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) Releases Fiscal 2019 Q2 Financial Results, Achieves $5.9M Revenue Milestone

IONIC Brands (CSE: IONC) (OTC: IONKF) (FRA: IB3) on Thursday released its second quarter 2019 financial results as it achieves a $5.9M revenue milestone for the first half of year. The company reported highlights for the quarter ended June 30, 2019 that include completion of a number of strategic acquisitions, as well as a concurrent brokered and non-brokered debenture unit offering raising approximately C$20 million in gross proceeds. “We are very pleased with our second quarter financial results, achieving our focus of increasing sales growth while closing a successful financing for various strategic business acquisitions all in a span of three months,” John Gorst, chairman and CEO of IONIC Brands said in the news release.

To view the full press release, visit http://cnw.fm/2Wqrc

About IONIC Brands Corp.

IONIC Brands is focused on building a multi-state consumer-focused cannabis concentrate brand portfolio focusing on the premium and luxury segments. The cornerstone brand of the portfolio, IONIC, is the No. 1 vaporizer brand in Washington State and has aggressively expanded throughout the West Coast of the United States. The brand is currently operating in Washington, Nevada, Oregon and California. IONIC BRANDS’ strategy is to be the leader of the highest-value segments of the cannabis market and expand nationally. For more information, visit the company’s website at www.IONIC.social.

NOTE TO INVESTORS: The latest news and updates relating to IONKF are available in the company’s newsroom at http://cnw.fm/IONC

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Study Announced to Investigate Effect of Medical Marijuana on Driver Performance

The Australian government has given a pharmaceutical company permission to study how medical marijuana affects the driving performance of patients.

As the acceptance of medical cannabis increases around the world, concerns have been raised regarding the potential effects of this medicine on road safety. Currently, many jurisdictions in Australia have laws banning patients who take medical marijuana from driving. These bans are premised on fears that the substance could impair the drivers.

The driving restrictions imposed on drivers, as well as the complex bureaucracy that patients must negotiate before they can be enrolled on the medical cannabis program, have limited the rate at which the medical cannabis program is embraced by people in Australia.

In fact, there have been reports of patients who are advised to try medical marijuana to manage their conditions and they decline because they aren’t willing to forego their liberty to drive in exchange for using medical marijuana.

The cannabinoid known to cause a “high” is THC, and medical marijuana products contain it in varying degrees. However, CBD is the most commonly used cannabinoid in medical marijuana products and it doesn’t make users high. That notwithstanding, it isn’t clear whether CBD can impair one’s ability to drive even if it isn’t euphoric.

That is the question that the makers of CannEpil, a medical cannabis product that contains a 20:1 ratio of CBD and THC, want to answer during this trial. This medicine was developed to treat epilepsy that is unresponsive to existing drugs.

This medication is currently available in the UK and Australia in the category of “investigational medicines.” This classification is given to drugs that have not yet been approved by regulators and are still being studied.

The trial will be conducted as a collaboration between MGC Pharmaceuticals (the makers of the drug), the University of Melbourne, and the Swinburne University of Technology. The study will also be used by the European Medicines Agency (EMA) and Australia’s Therapeutic Goods Administration (ATA) as a source of safety data about the drug.

During the trail, 30 patients will be divided into two groups. One group will receive a placebo while the other group will take CannEpil. The test subjects will then be subjected to driving performance tests using a hi-tech driving simulator provided by the University of Swinburne. The tests are expected to be conducted over a 14-day period.

Analysts believe that industry players like IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) and Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) will be looking forward to the results of this trial since it could open a serious discussion about some of the myths associated with medical marijuana.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Female Legislators from Across the US Hold Marijuana Conference in Colorado

A total of thirty female state legislators from across the country have converged in Denver, Colorado to attend a marijuana policy summit. This summit is organized by the National Foundation for Women Legislators (NFWL).

The female lawmakers who attend this event will learn about the way in which marijuana laws have been evolving, how the industry is licensed and taxed, the available science on the public health concerns regarding marijuana, and many other topics.

The participants in this summit will also be given an opportunity to tour a facility where marijuana is dispensed so that the lawmakers can witness the process and interact with the people working at that dispensary.

The website of the event states that NFWL is bringing together female lawmakers from states where cannabis is already legal or is in the process of being legalized so that the legislators can learn from one another. This two-day summit ends today and we shall be bringing you the details of what transpired.

Nine foundation members are scheduled to address the summit. The most notable of this group includes Rep. Kimberly Dudik (D) from Montana who is planning to contest to become the attorney general of the state. Others are Sen. Donna Kim (D) from Hawaii, Rep. Lois Landgraf (R) from Colorado and Rep. Karen Camper (D) from Tennessee.

In total, eight marijuana panels are planned for the event. The first panel will focus on the marijuana policies in different states, starting with Colorado which legalized marijuana first. The policies of the states that legalized later on will also be discussed to give the summit its proper legal context.

The second panel will focus on commercial marijuana operations. Here, the different marijuana products and their potency will be discussed, followed by an overview of the different categories into which these products are bunched together for licensing purposes. Other licenses in the industry will also be covered.

Another panel will look at marijuana and human health. The focus of this particular panel discussion will be on CBD and the need for clinical trials to be done so that more information can be availed regarding the potential of this compound. There will be a discussion of how the healthcare system is working in the wake of the marijuana industry.

Another panel at the summit will look at the importance of public safety. Here, the experience of cannabis legalization in Colorado will be looked at as a case study of the different law enforcement challenges that emerged after legalization and the lessons learned from the expected and unexpected public health consequences of marijuana legalization.

In short, the panels will cover the entire gamut of issues connected to marijuana legalization so that participants can leave when they are better equipped to make the right decisions when these issues come up for debate in their jurisdictions.

Experts are convinced that summits like this one held in Colorado are good news to industry players like Hemptown USA and IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) because the events normalize conversations about marijuana and result in rational decisions about the substance.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Mexican Government Seeks Public Input on Plans to Legalize Marijuana

Mexican legislators have announced plans to hold a series of public meetings in order to gather information on how the public thinks the government should handle the matter of legalizing recreational marijuana in the country. The meetings are planned for August 12, 14 and 16.

The announcements indicate that Mexicans will be free to pass on their suggestions on five different aspects of marijuana legalization. These are public health issues, matters of human rights, how to develop drugs derived from marijuana, how to prevent access to marijuana by minors and how to deal with marijuana addiction.

A translation of the information carried on the government website indicates that the move towards legalizing marijuana is motivated by several factors which include the changing attitude towards prohibition at the international level and the Supreme Court ruling that declared banning the recreational use of marijuana by adults as unconstitutional. These factors made it necessary to give serious thought to creating a regulated marijuana industry in the country.

The Mexican Senate has created a page where members of the public can find all the details about the planned meetings, as well as how interested people can register to attend the meetings in person. There is also a provision for Mexicans to submit their comments using an online form provided on the website.

The website also indicates that many bills related to marijuana legalization have been filed before the Senate and the content of those bills would form part of what is discussed during the public meetings.

Before the legislative committees start examining those bills, public input will be collected in a transparent and inclusive way so that the final legislation passed will be a true reflection of what the people of Mexico want at this time.

It should be remembered that a few months ago, Julio Ramon Salazar, the chair of the Senate Justice Committee, announced that his committee would use the summer recess to draft a law for the legalization of marijuana in the country.

While there are at least 10 bills seeking to reform Mexico’s marijuana policies, it is widely believed that the bill introduced by Olga Sanchez Cordero, the Mexican Secretary of Interior, is the one that is most likely to be passed by the lawmakers.

Marijuana reform is supported to the very top tiers of decision making in Mexico, with President Manuel Obrador saying that it is unsustainable to continue the war on drugs. He even went so far as suggesting in his National Development Plan that marijuana should be decriminalized.

Marijuana industry analysts would be eager to know what players like IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) and Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) think will be the regional ramifications of Mexico legalizing marijuana.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com